openPR Logo
Press release

Cholera Vaccine Market To See Record Break Revenue $207 Million By 2025 | Valneva SE, Astellas Pharma, Inc

03-11-2021 03:14 PM CET | Health & Medicine

Press release from: Allied Market Research

Cholera Vaccine Market

Cholera Vaccine Market

Lack of proper sanitation, increase in awareness regarding preventive care for cholera, and development of innovative approaches for cholera vaccine drive the growth in the global cholera vaccine market

The global cholera vaccine market contributed nearly $65 million in 2017 and is expected to reach $207 million by 2025, registering a CAGR of 15.6% from 2018 to 2025.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/5177?reqfor=covid

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

However, time taken for regulatory approvals and risks related to adverse effects restrain the market growth. On the other hand, opportunities in emerging economies create new pathways in the industry.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5177

Dukoral to maintain its dominant share by 2025

Dukoral contributed the highest market share of nearly half of the total market in 2017 and is expected to maintain its dominant share by 2025. This is due to the established pile of the oral cholera vaccine by the World Health Organization (WHO) and rise in the number of travelers to the low- and middle-income countries (LMICs). However, Vaxchora is expected to register the highest growth rate, with a CAGR of 17.2% from 2018 to 2025, owing to its benefits such as single dose immunization, reduction in adverse effects, and high efficacy rate for prevention of cholera.

Hospitals and clinics to maintain its lead status throughout the forecast period

Hospitals and clinics accounted for nearly three-fifths of the total market share in 2017 and will maintain its lead status throughout the forecast period. This is due to increase in the incidences of cholera, demand for immunization, the availability of highly-skilled and qualified professionals in the hospitals, and preference of patients. However, the research & academic laboratories segment is expected to grow at a CAGR of 16.4% during the forecast period, owing to surge in demand for cholera vaccine across the globe for more effective and cost efficient cholera vaccines.

North America to grow fastest

North America is expected to grow at the highest growth rate, with a CAGR of 15.4% from 2018 to 2025, owing to the launch of Vaxchora, the first and only oral cholera vaccine in the U.S. and the increase in immunization. However, Asia-Pacific contributed nearly two-fifths of the total market share in 2017 and will lead throughout the forecast period. This is due to rise in prevalence of cholera disease in low-and middle-income countries leading to the increase in importance of immunization, surge in healthcare spending, and upsurge in awareness regarding cholera preventive care.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/cholera-vaccine-market

The Major Key Players Are:

Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited), Eubiologics Co., Ltd., and Johnson & Johnson (Crucell), Celldex Therapeutics, Inc.

The other Key players are:

Merck & Co., Inc., GlaxoSmithKline plc., and others

Similar Reports:

Alopecia Treatment Market : https://www.pharmiweb.com/press-release/2020-09-29/alopecia-treatment-market-top-companies-analysis-to-growing-at-cagr-of-46-by-2026

India Medical Implants Market : https://www.pharmiweb.com/press-release/2020-09-29/india-medical-implants-market-top-companies-analysis-to-grow-your-business-in-2027-1

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cholera Vaccine Market To See Record Break Revenue $207 Million By 2025 | Valneva SE, Astellas Pharma, Inc here

News-ID: 2255206 • Views:

More Releases from Allied Market Research

A Deep Drive Into GMO Testing Market to Generate $3.9 Billion by 2031
A Deep Drive Into GMO Testing Market to Generate $3.9 Billion by 2031
GMO testing market is predicted to garner a revenue of $6.2 billion by 2031. The market was valued at $3.9 billion in 2021 and is estimated to experience a growth at a CAGR of 4.8% during the 2022-2031 period. The growth of GMO testing can be attributed to several factors, including increasing consumer demand for transparency and information about the food they eat, the need for reliable and accurate testing methods
Aircraft Fuel Systems Market Expected To Reach $15.7 Bn By 2032 At A CAGR Of 6.5% During A Forecast Period
Aircraft Fuel Systems Market Expected To Reach $15.7 Bn By 2032 At A CAGR Of 6.5 …
The aircraft fuel systems industry was valued at $8.5 billion in 2022, and is estimated to reach $15.7 billion by 2032, growing at a CAGR of 6.5% from 2023 to 2032. The commercial aviation industry is experiencing notable growth due to various factors such as the expansion of global trade, economic advancement, and enhanced connectivity. This growth directly leads to an increased need for fuel systems in commercial aircraft. Furthermore, airlines are
Dairy Free Cream Liqueur Market Size is Growing at a CAGR of 10.8% and Reach $4.2 Billion by 2031
Dairy Free Cream Liqueur Market Size is Growing at a CAGR of 10.8% and Reach $4. …
Dairy free cream liqueur market was valued at $1.5 billion in 2021, and is estimated to reach $4.2 billion by 2031, growing at a CAGR of 10.8% from 2022 to 2031. Rise in consumption of vegan food & beverage products is expected to boost the demand for dairy free cream liqueur. Appealing flavor combinations and attractive packaging designs are anticipated to further increase the sales of dairy free cream liqueurs. Download Sample
Laminated Timber Market Growth, Business Trends, and Progress Insight, 20331
Laminated Timber Market Growth, Business Trends, and Progress Insight, 20331
Allied Market Research published a report, titled, "Laminated Timber Market by Type (Cross-Laminated Timber (CLT), Glue Laminated Timber (Gulam), Laminated Veneer Lumbar (LVL), Others), by End-Use Industry (Residential, Non-Residential): Global Opportunity Analysis and Industry Forecast, 2021- 2031". According to the report, the global laminated timber industry generated $1.6 billion in 2021, and is anticipated to generate $3.5 billion by 2031, witnessing a CAGR of 8.1% from 2022 to 2031. Request

All 5 Releases


More Releases for Cholera

Hog Cholera Vaccine Market Increasing concerns over hog cholera outbreaks and th …
Global Hog Cholera Vaccine Market Overview: The Hog Cholera Vaccine market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Hog Cholera Vaccine market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth
Global Cholera Treatment Market Scope and Market Size
Data Bridge Market Research analyses that the cholera treatment will exhibit a CAGR of around 8.58% for the forecast period of 2021-2028. Growing demand for target mode of therapies, increased focus on the strategic initiatives by the market players to initiate new product launches, surge in the research and development activities for the development of novel drugs and therapies, high demand for drugs used to treat risks associated with tularemia
Oral Cholera Vaccine Market is Thriving Worldwide with Top Companies like: Sanof …
Los Angeles, United State, –The report titled Global Oral Cholera Vaccine Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Oral Cholera Vaccine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of
Cholera Treatment Market Growth Report 2016- 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular
Cholera Treatment Market, Industry Research report, Forecasts upto 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular
Cholera Treatment Market: Opportunities and Forecasts, 2014
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular